Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients

Area of Science:

• Genetics and Molecular Biology
• Infectious Diseases
• Immunology

Background:

• Iron acquisition is crucial for Mycobacterium tuberculosis (M.tb.) growth.
• Hepcidin, an antimicrobial peptide, inhibits M.tb. growth in vitro.
• The study investigates the HAMP gene's -582A>G promoter variants in tuberculosis (TB).

Purpose of the Study:

• To identify -582A>G variants of the HAMP promoter in TB patients.
• To examine the association between these variants and serum iron, ferritin, and hepcidin levels.
• To explore the role of hepcidin in TB pathogenesis and iron metabolism.

Main Methods:

• Genotyping of the -582A>G polymorphism using tetra-primers PCR.
• Quantification of serum hepcidin levels via ELISA.
• Statistical analysis of 105 TB patients and 104 healthy controls.

Main Results:

• The G allele of the HAMP -582A>G variant showed a significant association with TB disease (p < 0.000).
• Significant differences in serum iron and hepcidin levels were observed across genotypes, but not ferritin.
• A strong inverse correlation between serum hepcidin and iron levels was found (r = -0.849, p = 0.006).

Conclusions:

• A significant association exists between serum hepcidin levels and HAMP -582A>G variants in TB patients.
• The findings suggest a potential role for this polymorphism in regulating iron metabolism during TB.
• Hepcidin warrants further investigation as a potential therapeutic target for TB.